Rotolo R, Leuci V, Donini C, Galvagno F, Massa A, De Santis MC, Peirone S, Medico G, Sanlorenzo M, Vujic I, Gammaitoni L, Basiricò M, Righi L, Riganti C, Salaroglio IC, Napoli F, Tabbò F, Mariniello A, Vigna E, Modica C, D'Ambrosio L, Grignani G, Taulli R, Hirsch E, Cereda M, Aglietta M, Scagliotti GV, Novello S, Bironzo P, Sangiolo D

Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells.

Clin Cancer Res 2023; 621-634. doi: 10.1158/1078-0432.CCR-22-0761

Takaoka Y, Fujibayashi S, Yabutsuka T, Yamane Y, Ishizaki C, Goto K, Otsuki B, Kawai T, Shimizu T, Okuzu Y, Masamoto K, Shimizu Y, Hayashi M, Ikeda N, Matsuda S

Synergistic effect of sulfonation followed by precipitation of amorphous calcium phosphate on the bone-bonding strength of carbon fiber reinforced polyetheretherketone.

Sci Rep 2023; 1443. doi: 10.1038/s41598-023-28701-1

Menin L, Weber J, Villa S, Martini E, Maspero E, Cancila V, Maiuri P, Palamidessi A, Frittoli E, Bianchi F, Tripodo C, Walters KJ, Giavazzi F, Scita G, Polo S

A planar-polarized MYO6-DOCK7-RAC1 axis promotes tissue fluidification in mammary epithelia.

bioRxiv 2023; . doi: 10.1101/2023.01.23.524898

Khawaja H, Briggs R, Latimer CH, Rassel M, Griffin D, Hanson L, Bardelli A, Di Nicolantonio F, McDade SS, Scott CJ, Lambe S, Maurya M, Lindner AU, Prehn JHM, Sousa J, Winnington C, LaBonte MJ, Ross S, Van Schaeybroeck S

Bcl-xL Is a Key Mediator of Apoptosis Following KRASG12C Inhibition in KRASG12C-mutant Colorectal Cancer.

Mol Cancer Ther 2023; 135-149. doi: 10.1158/1535-7163.MCT-22-0301

Govetto A, Bacherini D, Romano MR, Matteucci M, Lucchini S, Cifarelli L, Dragotto F, Cereda M, Parrulli S, Staurenghi G, Giansanti F, Virgili G, Bottoni F, Radice P

Full-Thickness Macular Hole: Are Supra-RPE Granular Deposits Remnants of Photoreceptors Outer Segments? Clinical Implications.

Am J Ophthalmol 2023; 86-101. doi: 10.1016/j.ajo.2022.09.005

Ferrando L, Vingiani A, Garuti A, Vernieri C, Belfiore A, Agnelli L, Dagrada G, Ivanoiu D, Bonizzi G, Munzone E, Lippolis L, Dameri M, Ravera F, Colleoni M, Viale G, Magnani L, Ballestrero A, Zoppoli G, Pruneri G

ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC).

PLoS Genet 2023; e1010563. doi: 10.1371/journal.pgen.1010563

Provenzano L, Lobefaro R, Ligorio F, Zattarin E, Zambelli L, Sposetti C, Presti D, Montelatici G, Ficchì A, Martinetti A, Arata A, Del Vecchio M, Lauria Pantano C, Formisano B, Bianchi GV, Capri G, de Braud F, Vernieri C, Fucà G

The pan-immune-inflammation value is associated with clinical outcomes in patients with advanced TNBC treated with first-line, platinum-based chemotherapy: an institutional retrospective analysis.

Ther Adv Med Oncol 2023; 17588359231165978. doi: 10.1177/17588359231165978

Zattarin E, Mariani L, Menichetti A, Leporati R, Provenzano L, Ligorio F, Fucà G, Lobefaro R, Lalli L, Vingiani A, Nichetti F, Griguolo G, Sirico M, Bernocchi O, Marra A, Corti C, Zagami P, Agostinetto E, Jacobs F, Di Mauro P, Presti D, Sposetti C, Giorgi CA, Guarneri V, Pedersini R, Losurdo A, Generali D, Curigliano G, Pruneri G, de Braud F, Dieci MV, Vernieri C

Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors.

Ther Adv Med Oncol 2023; 17588359231204857. doi: 10.1177/17588359231204857

Monti M, Ferrari G, Grosso V, Missale F, Bugatti M, Cancila V, Zini S, Segala A, La Via L, Consoli F, Orlandi M, Valerio A, Tripodo C, Rossato M, Vermi W

Impaired activation of plasmacytoid dendritic cells via toll-like receptor 7/9 and STING is mediated by melanoma-derived immunosuppressive cytokines and metabolic drift.

Front Immunol 2023; 1227648. doi: 10.3389/fimmu.2023.1227648

Rizzello C, Cancila V, Sangaletti S, Botti L, Ratti C, Milani M, Dugo M, Bertoni F, Tripodo C, Chiodoni C, Colombo MP

Intracellular osteopontin protects from autoimmunity-driven lymphoma development inhibiting TLR9-MYD88-STAT3 signaling.

Mol Cancer 2022; 215. doi: 10.1186/s12943-022-01687-6

Kerschbamer E, Arnoldi M, Tripathi T, Pellegrini M, Maturi S, Erdin S, Salviato E, Di Leva F, Sebestyén E, Dassi E, Zarantonello G, Benelli M, Campos E, Basson MA, Gusella JF, Gustincich S, Piazza S, Demichelis F, Talkowski ME, Ferrari F, Biagioli M

CHD8 suppression impacts on histone H3 lysine 36 trimethylation and alters RNA alternative splicing.

Nucleic Acids Res 2022; 12809-12828. doi: 10.1093/nar/gkac1134

Ligorio F, Di Cosimo S, Verderio P, Ciniselli CM, Pizzamiglio S, Castagnoli L, Dugo M, Galbardi B, Salgado R, Loi S, Michiels S, Triulzi T, Tagliabue E, El-Abed S, Izquierdo M, de Azambuja E, Nuciforo P, Huober J, Moscetti L, Janni W, Coccia-Portugal MA, Corsetto PA, Belfiore A, Lorenzini D, Daidone MG, Vingiani A, Gianni L, Pupa SM, Bianchini G, Pruneri G, Vernieri C

Predictive Role of CD36 Expression in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Trastuzumab.

J Natl Cancer Inst 2022; 1720-1727. doi: 10.1093/jnci/djac126

Flanagan DJ, Amirkhah R, Vincent DF, Gunduz N, Gentaz P, Cammareri P, McCooey AJ, McCorry AMB, Fisher NC, Davis HL, Ridgway RA, Lohuis J, Leach JDG, Jackstadt R, Gilroy K, Mariella E, Nixon C, Clark W, Hedley A, Markert EK, Strathdee D, Bartholin L, Redmond KL, Kerr EM, Longley DB, Ginty F, Cho S, Coleman HG, Loughrey MB, Bardelli A, Maughan TS, Campbell AD, Lawler M, Leedham SJ, Barry ST, Inman GJ, van Rheenen J, Dunne PD, Sansom OJ

Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features.

Nat Commun 2022; 7551. doi: 10.1038/s41467-022-35134-3

Schrempf A, Bernardo S, Arasa Verge EA, Ramirez Otero MA, Wilson J, Kirchhofer D, Timelthaler G, Ambros AM, Kaya A, Wieder M, Ecker GF, Winter GE, Costanzo V, Loizou JI

POLθ processes ssDNA gaps and promotes replication fork progression in BRCA1-deficient cells.

Cell Rep 2022; 111716. doi: 10.1016/j.celrep.2022.111716

Mann A, Ramirez-Otero MA, De Antoni A, Hanthi YW, Sannino V, Baldi G, Falbo L, Schrempf A, Bernardo S, Loizou J, Costanzo V

POLθ prevents MRE11-NBS1-CtIP-dependent fork breakage in the absence of BRCA2/RAD51 by filling lagging-strand gaps.

Mol Cell 2022; 4218-4231.e8. doi: 10.1016/j.molcel.2022.09.013

Chondronasiou D, Martínez de Villarreal J, Melendez E, Lynch CJ, Pozo ND, Kovatcheva M, Aguilera M, Prats N, Real FX, Serrano M

Deciphering the roadmap of in vivo reprogramming toward pluripotency.

Stem Cell Reports 2022; 2501-2517. doi: 10.1016/j.stemcr.2022.09.009

Conte MI, Poli MC, Taglialatela A, Leuzzi G, Chinn IK, Salinas SA, Rey-Jurado E, Olivares N, Veramendi-Espinoza L, Ciccia A, Lupski JR, Aldave Becerra JC, Mace EM, Orange JS

Partial loss-of-function mutations in GINS4 lead to NK cell deficiency with neutropenia.

JCI Insight 2022; . doi: 10.1172/jci.insight.154948

Mauceri R, Coppini M, Vacca D, Bertolazzi G, Panzarella V, Di Fede O, Tripodo C, Campisi G

Salivary Microbiota Composition in Patients with Oral Squamous Cell Carcinoma: A Systematic Review.

Cancers (Basel) 2022; . doi: 10.3390/cancers14215441

Pasqualetti F, Rizzo M, Franceschi S, Lessi F, Paiar F, Buffa FM

New perspectives in liquid biopsy for glioma patients.

Curr Opin Oncol 2022; 705-712. doi: 10.1097/CCO.0000000000000902

Matis S, Grazia Recchia A, Colombo M, Cardillo M, Fabbi M, Todoerti K, Bossio S, Fabris S, Cancila V, Massara R, Reverberi D, Emionite L, Cilli M, Cerruti G, Salvi S, Bet P, Pigozzi S, Fiocca R, Ibatici A, Angelucci E, Gentile M, Monti P, Menichini P, Fronza G, Torricelli F, Ciarrocchi A, Neri A, Fais F, Tripodo C, Morabito F, Ferrarini M, Cutrona G

MiR-146b-5p regulates IL-23 receptor complex expression in chronic lymphocytic leukemia cells.

Blood Adv 2022; 5593-5612. doi: 10.1182/bloodadvances.2021005726

Li Y, Goldberg EM, Chen X, Xu X, McGuire JT, Leuzzi G, Karagiannis D, Tate T, Farhangdoost N, Horth C, Dai E, Li Z, Zhang Z, Izar B, Que J, Ciccia A, Majewski J, Yoon AJ, Ailles L, Mendelsohn CL, Lu C

Histone methylation antagonism drives tumor immune evasion in squamous cell carcinomas.

Mol Cell 2022; 3901-3918.e7. doi: 10.1016/j.molcel.2022.09.007

Varone E, Chernorudskiy A, Cherubini A, Cattaneo A, Bachi A, Fumagalli S, Erol G, Gobbi M, Lenardo MJ, Borgese N, Zito E

ERO1 alpha deficiency impairs angiogenesis by increasing N-glycosylation of a proangiogenic VEGFA.

Redox Biol 2022; 102455. doi: 10.1016/j.redox.2022.102455

Chen Z, Ioris RM, Richardson S, Van Ess AN, Vendrell I, Kessler BM, Buffa FM, Busino L, Clifford SC, Bullock AN, D'Angiolella V

Disease-associated KBTBD4 mutations in medulloblastoma elicit neomorphic ubiquitylation activity to promote CoREST degradation.

Cell Death Differ 2022; 1955-1969. doi: 10.1038/s41418-022-00983-4

Romano F, Zicarelli F, Cozzi M, Bertoni AI, Cereda MG, Bottoni F, Staurenghi G, Invernizzi A

MULTIMODAL IMAGING CHARACTERISTICS AND FUNCTIONAL CORRELATES IN RIP HEALING.

Retina 2022; 1844-1851. doi: 10.1097/IAE.0000000000003542

Del Giudice M, Foster JG, Peirone S, Rissone A, Caizzi L, Gaudino F, Parlato C, Anselmi F, Arkell R, Guarrera S, Oliviero S, Basso G, Rajan P, Cereda M

FOXA1 regulates alternative splicing in prostate cancer.

Cell Rep 2022; 111404. doi: 10.1016/j.celrep.2022.111404

Kaeppler JR, Chen J, Buono M, Vermeer J, Kannan P, Cheng WC, Voukantsis D, Thompson JM, Hill MA, Allen D, Gomes A, Kersemans V, Kinchesh P, Smart S, Buffa F, Nerlov C, Muschel RJ, Markelc B

Endothelial cell death after ionizing radiation does not impair vascular structure in mouse tumor models.

EMBO Rep 2022; e53221. doi: 10.15252/embr.202153221

Pergolizzi M, Bizzozero L, Maione F, Maldi E, Isella C, Macagno M, Mariella E, Bardelli A, Medico E, Marchiò C, Serini G, Di Nicolantonio F, Bussolino F, Arese M

The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathway.

J Exp Clin Cancer Res 2022; 266. doi: 10.1186/s13046-022-02465-4

Chauhan JS, Hölzel M, Lambert JP, Buffa FM, Goding CR

The MITF regulatory network in melanoma.

Pigment Cell Melanoma Res 2022; 517-533. doi: 10.1111/pcmr.13053

Harris BHL, Macaulay VM, Harris DA, Klenerman P, Karpe F, Lord SR, Harris AL, Buffa FM

Obesity: a perfect storm for carcinogenesis.

Cancer Metastasis Rev 2022; 491-515. doi: 10.1007/s10555-022-10046-2

Pezzotta A, Gentile I, Genovese D, Totaro MG, Battaglia C, Leung AY, Fumagalli M, Parma M, Cazzaniga G, Fazio G, Alcalay M, Marozzi A, Pistocchi A

HDAC6 inhibition decreases leukemic stem cell expansion driven by Hedgehog hyperactivation by restoring primary ciliogenesis.

Pharmacol Res 2022; 106378. doi: 10.1016/j.phrs.2022.106378

Durinikova E, Reilly NM, Buzo K, Mariella E, Chilà R, Lorenzato A, Dias JML, Grasso G, Pisati F, Lamba S, Corti G, Degasperi A, Cancelliere C, Mauri G, Andrei P, Linnebacher M, Marsoni S, Siena S, Sartore-Bianchi A, Nik-Zainal S, Di Nicolantonio F, Bardelli A, Arena S

Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer.

Clin Cancer Res 2022; 3874-3889. doi: 10.1158/1078-0432.CCR-22-0875

Ligorio F, Fucà G, Provenzano L, Lobefaro R, Zanenga L, Vingiani A, Belfiore A, Lorenzoni A, Alessi A, Pruneri G, de Braud F, Vernieri C

Exceptional tumour responses to fasting-mimicking diet combined with standard anticancer therapies: A sub-analysis of the NCT03340935 trial.

Eur J Cancer 2022; 300-310. doi: 10.1016/j.ejca.2022.05.046

Berrino E, Annaratone L, Bellomo SE, Ferrero G, Gagliardi A, Bragoni A, Grassini D, Guarrera S, Parlato C, Casorzo L, Panero M, Sarotto I, Giordano S, Cereda M, Montemurro F, Ponzone R, Crosetto N, Naccarati A, Sapino A, Marchiò C

Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas.

Genome Med 2022; 98. doi: 10.1186/s13073-022-01104-z

Cortellino S, Raveane A, Chiodoni C, Delfanti G, Pisati F, Spagnolo V, Visco E, Fragale G, Ferrante F, Magni S, Iannelli F, Zanardi F, Casorati G, Bertolini F, Dellabona P, Colombo MP, Tripodo C, Longo VD

Fasting renders immunotherapy effective against low-immunogenic breast cancer while reducing side effects.

Cell Rep 2022; 111256. doi: 10.1016/j.celrep.2022.111256

Sheldon H, Zhang W, Bridges E, Ang KH, Lin S, Masiero M, Li D, Handford PA, Whiteman P, Fischer R, Buffa F, Vatish M, Banham AH, Harris AL

ELTD1 is present in extracellular vesicles derived from endothelial cells as a cleaved extracellular domain which induces in vivo angiogenesis.

J Extracell Biol 2022; e52. doi: 10.1002/jex2.52

Mauri G, Vitiello PP, Sogari A, Crisafulli G, Sartore-Bianchi A, Marsoni S, Siena S, Bardelli A

Liquid biopsies to monitor and direct cancer treatment in colorectal cancer.

Br J Cancer 2022; 394-407. doi: 10.1038/s41416-022-01769-8

Sartore-Bianchi A, Pietrantonio F, Lonardi S, Mussolin B, Rua F, Crisafulli G, Bartolini A, Fenocchio E, Amatu A, Manca P, Bergamo F, Tosi F, Mauri G, Ambrosini M, Daniel F, Torri V, Vanzulli A, Regge D, Cappello G, Marchiò C, Berrino E, Sapino A, Marsoni S, Siena S, Bardelli A

Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial.

Nat Med 2022; 1612-1618. doi: 10.1038/s41591-022-01886-0

%PLACEHOLDER%